Anxiety, Overactive Bladder, Urinary Incontinence, Stress, Urinary Incontinence, Urge, Urinary Retention
Conditions
Keywords
Anxiety, Urodynamics, Symptom reproducibility, Lower urinary tract symptoms, Women
Brief summary
This study will look at how pre-test anxiety levels affect the reproducibility of symptoms during routine urodynamic testing in women. Urodynamics is a test that assesses the function of the lower urinary tract, including the bladder.
Detailed description
The results of urodynamic tests often determine treatment for patients, which may include bladder retraining, medication and/or surgery. Thus, it is important for the results of urodynamics to be accurate and representative of the patient's symptoms outside of the clinic. Pre-test anxiety levels in women undergoing urodynamics will be measured using a validated questionnaire HADS (Hospital anxiety and depression scale). The patient, prior to their routine urodynamics test, will fill out this self-administered questionnaire. Reproducibility of patient symptoms will be measured using a non-validated quantitative bladder test assessment. The patient will fill out this self-administered quantitative bladder assessment after their urodynamics test. The pre-test anxiety and symptom reproducibility variables will be correlated against each other to assess whether there is correlation between the two. A Spearman Rho test will be used to assess the strength of the relationship.
Interventions
None listed
Sponsors
Sheffield Teaching Hospitals NHS Foundation Trust
Sandwell & West Birmingham Hospitals NHS Trust
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 99 Years
Healthy volunteers
No
Inclusion criteria
* Women attending for their first time to the urodynamics clinic for the assessment of their bladder function * Must be over the age of 18 years old * Must be able to consent for themselves
Exclusion criteria
* Any patients not covered in the inclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Correlate pre-test anxiety scores with the reproducibility of symptom scores from urodynamic studies in women | 9 months |
Secondary
| Measure | Time frame |
|---|---|
| The number of women who have their typical symptoms reproduced during urodynamic studies | 9 months |
| Number of women with abnormal (i.e. not normal) urodynamic diagnosis and high pre-test anxiety scores | 9 months |
| Number of women with abnormal (i.e. not normal) urodynamic diagnosis with low reproducibility of symptom scores | 9 months |
Countries
United Kingdom
Outcome results
None listed